share_log

Industrial Alliance Initiates Coverage On NervGen Pharma with Speculative Buy Rating, Announces Price Target of $6

Benzinga Real-time News ·  Jul 13, 2021 08:55

Industrial Alliance initiates coverage on NervGen Pharma (OTC:NGENF) with a Speculative Buy rating and announces Price Target of $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment